CA2141126A1 - Medicament d'association pour le traitement de la migraine et d'autres affections - Google Patents

Medicament d'association pour le traitement de la migraine et d'autres affections

Info

Publication number
CA2141126A1
CA2141126A1 CA002141126A CA2141126A CA2141126A1 CA 2141126 A1 CA2141126 A1 CA 2141126A1 CA 002141126 A CA002141126 A CA 002141126A CA 2141126 A CA2141126 A CA 2141126A CA 2141126 A1 CA2141126 A1 CA 2141126A1
Authority
CA
Canada
Prior art keywords
composition
sesquiterpene lactone
complex vitamin
riboflavin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002141126A
Other languages
English (en)
Inventor
Natalie J. Lazarowych
Peter Pekos
Michael W. O'connell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASHBURY RESEARCH Corp
Original Assignee
ASHBURY RESEARCH CORPORATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASHBURY RESEARCH CORPORATION filed Critical ASHBURY RESEARCH CORPORATION
Priority to CA002141126A priority Critical patent/CA2141126A1/fr
Priority to KR1019970705116A priority patent/KR19980701720A/ko
Priority to AU44780/96A priority patent/AU4478096A/en
Priority to EP96900799A priority patent/EP0805680A2/fr
Priority to PCT/CA1996/000052 priority patent/WO1996022774A2/fr
Priority to JP8522519A priority patent/JPH10512573A/ja
Publication of CA2141126A1 publication Critical patent/CA2141126A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002141126A 1995-01-26 1995-01-26 Medicament d'association pour le traitement de la migraine et d'autres affections Abandoned CA2141126A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002141126A CA2141126A1 (fr) 1995-01-26 1995-01-26 Medicament d'association pour le traitement de la migraine et d'autres affections
KR1019970705116A KR19980701720A (ko) 1995-01-26 1996-01-25 세스키테르펜 락톤 및 비타민 b 복합체를 함유하는 편두통 및 기타 질환 치료용 복합약
AU44780/96A AU4478096A (en) 1995-01-26 1996-01-25 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
EP96900799A EP0805680A2 (fr) 1995-01-26 1996-01-25 Association medicamenteuse comprenant une sesquiterpene lactone et des vitamines du complexe b, destinee au traitement de la migraine et d'autres troubles
PCT/CA1996/000052 WO1996022774A2 (fr) 1995-01-26 1996-01-25 Association medicamenteuse comprenant une sesquiterpene lactone et des vitamines du complexe b, destinee au traitement de la migraine et d'autres troubles
JP8522519A JPH10512573A (ja) 1995-01-26 1996-01-25 セスキテルペンラクトンとビタミンｂ複合体とを含む片頭痛およびその他の疾病治療用複合剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002141126A CA2141126A1 (fr) 1995-01-26 1995-01-26 Medicament d'association pour le traitement de la migraine et d'autres affections

Publications (1)

Publication Number Publication Date
CA2141126A1 true CA2141126A1 (fr) 1996-07-27

Family

ID=4155120

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002141126A Abandoned CA2141126A1 (fr) 1995-01-26 1995-01-26 Medicament d'association pour le traitement de la migraine et d'autres affections

Country Status (6)

Country Link
EP (1) EP0805680A2 (fr)
JP (1) JPH10512573A (fr)
KR (1) KR19980701720A (fr)
AU (1) AU4478096A (fr)
CA (1) CA2141126A1 (fr)
WO (1) WO1996022774A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2283122A1 (fr) * 1997-03-03 1998-09-11 Laboratoires Remilea Compositions d'extraits de plantes, leur procede de preparation, et compositions pharmaceutiques les renfermant
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US6068999A (en) 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
DE19844836A1 (de) * 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
DE69904257T2 (de) 1999-01-20 2003-04-17 N.V. Nutricia, Zoetermeer Säuglingsnährpräparat
US6312736B1 (en) * 1999-12-09 2001-11-06 Biotech Corporation Herbal composition to relieve pain
US6890946B2 (en) 1999-12-23 2005-05-10 Indiana University Research And Technology Corporation Use of parthenolide to inhibit cancer
CA2406733A1 (fr) * 1999-12-23 2001-06-28 Harikrishna Nakshatri Utilisation du parthenolide pour inhiber le cancer
US7192614B2 (en) * 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
WO2008010335A1 (fr) * 2006-07-21 2008-01-24 Mmt Co., Ltd. Extrait végétal ayant un effet préventif sur l'arthrite
WO2008075649A1 (fr) * 2006-12-20 2008-06-26 Mmt Co., Ltd. Boisson, aliment, alicament, composition médicinale et procédé destinés à favoriser la croissance capillaire
WO2008075466A1 (fr) * 2006-12-20 2008-06-26 Mmt Co., Ltd. Boisson, aliment, alicament, composition pharmaceutique et procédé destinés à favoriser la croissance capillaire
CN101278928B (zh) 2007-04-06 2011-09-07 常州高新技术产业开发区三维工业技术研究所有限公司 含左卡尼汀或其衍生物的药物组合物及其用途
US20100284986A1 (en) * 2009-05-06 2010-11-11 Kelleher Kevin J Compositions and methods for prevention and treatment of migraines
IT201700085185A1 (it) * 2017-07-26 2019-01-26 Cristalfarma S R L Integratore alimentare per uso come coadiuvante nel trattamento e profilassi dell’emicrania

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4173M (fr) * 1965-02-01 1966-05-23
CA1270843A (fr) * 1982-05-19 1990-06-26 Edward Stewart Johnson Lactones sesquiterpenes
US4542026A (en) * 1983-04-29 1985-09-17 Jose Rios Method of treating vasomotor disorders
JPS63303915A (ja) * 1987-06-05 1988-12-12 Nikko Sogyo Kk 養毛用組成物
DE3808141A1 (de) * 1988-03-11 1989-09-21 Mai Jutta Mittel zur bekaempfung von migraene
JPH0713021B2 (ja) * 1991-08-01 1995-02-15 文夫 堂園 消化器系疾患治療用内服薬剤
JPH05306231A (ja) * 1992-04-24 1993-11-19 Pola Chem Ind Inc 皮膚外用剤
WO1994001899A1 (fr) * 1992-07-02 1994-01-20 W. L. Gore & Associates, Inc. Chassis d'etancheite et membrane protectrice pour antenne de radar parabolique et a cornet

Also Published As

Publication number Publication date
WO1996022774A2 (fr) 1996-08-01
JPH10512573A (ja) 1998-12-02
KR19980701720A (ko) 1998-06-25
EP0805680A2 (fr) 1997-11-12
WO1996022774A3 (fr) 1996-09-26
AU4478096A (en) 1996-08-14

Similar Documents

Publication Publication Date Title
CA2141126A1 (fr) Medicament d'association pour le traitement de la migraine et d'autres affections
US5196436A (en) Dextromethorphan antitussive compositions
US4965252A (en) Cholesterol-lowering combination compositions of guar gum and niacin
TW389696B (en) Accelerated release composition containing bromocriptine
JP4445590B2 (ja) パロキセチン−レジン含有の経口液体組成物
CA2020018A1 (fr) Methode et compose pour le traitement du complexe migraineux
JP2002506809A (ja) スタチンおよびアスピリン含有医薬組成物
JP2931409B2 (ja) パラセタモール及びドンペリドンのフィルムコーティング錠
SA520411808B1 (ar) أقراص ديفيريبرون مؤخرة الإطلاق وطرق لاستخدامها
US5702723A (en) Multi-stage delivery system for ingestible medications or nutrients
JP3018160B2 (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤
RU2528897C2 (ru) Рецептура для перорального трансмукозального применения гиполипидемических лекарственных средств
TWI240638B (en) A film-coated solid-dosage form pharmaceutical composition
JPS59112948A (ja) コレステロ−ルレベル低下剤
JPS61183220A (ja) 鎮痛性を有する医薬組成物
JP3170855B2 (ja) イブプロフェン含有解熱鎮痛剤
RU2261098C2 (ru) Перорально распадающаяся композиция, содержащая миртазапин
JP2001518481A (ja) 経口投与のためのセロトニン含有製剤及びその使用方法
JP2002543160A (ja) 医薬処方
US20030186938A1 (en) Water dispersible formulation of paroxetine
AU2003224419A1 (en) Orally administrable pharmaceutical formulation
EP0555411A1 (fr) Compositions antitussives contenant du dextromethorphan
JPH05201861A (ja) デキストロメトルフアンの鎮咳効果の増強
EA007571B1 (ru) Микрокапсулы для отсроченного и регулируемого высвобождения периндоприла
JP2016216371A (ja) ロスバスタチン含有口腔内速崩壊錠

Legal Events

Date Code Title Description
FZDE Dead